Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2019 Nov 1;21(11):1678-1685.
doi: 10.1093/europace/euz189.

Clinical safety of the ProMRI implantable cardioverter-defibrillator systems during head and lower lumbar magnetic resonance imaging at 3 T: results of the ProMRI 3T ENHANCED Master study

Affiliations
Multicenter Study

Clinical safety of the ProMRI implantable cardioverter-defibrillator systems during head and lower lumbar magnetic resonance imaging at 3 T: results of the ProMRI 3T ENHANCED Master study

Rainer Zbinden et al. Europace. .

Abstract

Aims: There have been no published studies on the safety of magnetic resonance imaging (MRI) at 3 Tesla (3 T) in patients with MRI-conditional implantable cardioverter-defibrillators (ICDs). The aim of this study was to assess clinical safety of the Biotronik ProMRI ICD system during non-diagnostic head and lower lumbar scans under 3 T MRI conditions.

Methods and results: The study enrolled 129 patients at 12 sites in Australia, Singapore, and Europe. Predefined head and lower lumbar MR scans (total duration ≈30 min) were performed in 112 patients. Three primary endpoints were evaluated from the pre-MRI to the 1-month post-MRI visit: (i) freedom from serious adverse device effects (SADEs) related to MRI (hypothesized to be >90%); (ii) pacing threshold invariance for all leads (geometric mean of the patient-wise ratios for 1 month vs. pre-MRI was hypothesized to be <1.07); and (iii) sensing amplitude invariance (geometric mean of the ratios was hypothesized to be >0.993). No MRI-related SADE occurred (SADE-free rate 100%, 95% confidence interval 95.98-100%). Pacing threshold and sensing amplitudes fulfilled the invariance hypotheses with high statistical significance (P < 0.0013). No threshold increase >0.5 V or sensing amplitude decrease by >50% was observed (secondary endpoints). Lead impedances, battery capacity, and detection and treatment of arrhythmias by ICDs were not affected by MRI scans.

Conclusion: The head and lower lumbar scans under specific 3 T MRI conditions were safe in the investigated MR-conditional ICD systems. There was no evidence of harm to the patients or any negative influence of the MRI scan on the implanted systems.

Keywords: Electromagnetic interference; Implantable cardioverter-defibrillator; Magnetic resonance imaging; ProMRI; Safety.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flow chart of the study. MRI, magnetic resonance imaging.
Figure 2
Figure 2
Isocenters at eye and hip level of magnetic resonance imaging scans. The shaded area in between depicts the scan exclusion zone.
Figure 3
Figure 3
Box- and whisker plot distributions of lead parameters measured in office. Whiskers extend from the upper and lower hinge no further than 1.5*IQR from each hinge, rhombi denote mean values. The unusually large RA amplitudes (≥15 mV) were measured in patients with DX ICD devices, which amplify the atrial signal up to four-fold. DX ICD, single-chamber implantable cardioverter-defibrillator with atrial diagnostics (atrial sensing via floating dipole); FU, follow-up; IQR, interquartile range; M, month; MRI, magnetic resonance imaging; RA, right atrial; RV, right ventricular.

References

    1. Roguin A, Schwitter J, Vahlhaus C, Lombardi M, Brugada J, Vardas P. et al. Magnetic resonance imaging in individuals with cardiovascular implantable electronic devices. Europace 2008;10:336–46. - PubMed
    1. Grover VP, Tognarelli JM, Crossey MM, Cox IJ, Taylor-Robinson SD, McPhail MJ.. Magnetic resonance imaging: principles and techniques: lessons for clinicians. J Clin Exp Hepatol 2015;5:246–55. - PMC - PubMed
    1. Nordbeck P, Ertl G, Ritter O.. Magnetic resonance imaging safety in pacemaker and implantable cardioverter defibrillator patients: how far have we come? Eur Heart J 2015;36:1505–11. - PMC - PubMed
    1. Lowe MD, Plummer CJ, Manisty CH, Linker NJ.. Safe use of MRI in people with cardiac implantable electronic devices. Heart 2015;101:1950–3. - PubMed
    1. Miller JD, Nazarian S, Halperin HR.. Implantable electronic cardiac devices and compatibility with magnetic resonance imaging. J Am Coll Cardiol 2016;68:1590–8. - PubMed

Publication types